Deferred Tax Assets, Valuation Allowance of AIM ImmunoTech Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AIM ImmunoTech Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • AIM ImmunoTech Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $42,879,000, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

AIM ImmunoTech Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $42,879,000 +$6,063,000 +16% 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q4 2023 $36,816,000 +$5,976,000 +19% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q4 2022 $30,840,000 +$7,129,000 +30% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $23,711,000 +$14,274,000 +151% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $9,437,000 -$35,031,000 -79% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $44,468,000 +$4,307,000 +11% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $40,161,000 +$2,036,000 +5.3% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q4 2017 $38,125,000 -$20,971,000 -35% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q4 2016 $59,096,000 +$1,955,000 +3.4% 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q4 2015 $57,141,000 +$4,697,000 +9% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q4 2014 $52,444,000 +$3,820,000 +7.9% 31 Dec 2014 10-K 29 Mar 2016 2015 FY
Q4 2013 $48,624,000 +$5,983,000 +14% 31 Dec 2013 10-K 19 Mar 2015 2014 FY
Q4 2012 $42,641,000 +$4,838,000 +13% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 $37,803,000 31 Dec 2011 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.